01273 704473

info@novuscomms.com

01273 704473

info@novuscomms.com

#TSP TruSpine Technologies PLC – Holdings in Company May 29, 2025 – Posted in: TruSpine Plc (TSP)

TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: TruSpine Technologies PLC 1b. Please indicate if the issuer is a non-UK issuer  (please mark with an “X” if appropriate) Non-UK issuer 2. Reason for…

Continue reading

#TSP TruSpine Technologies PLC – Convertible Loan Note Extension & RPT July 24, 2024 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, that further to the announcement on 28 March 2024, the Company has extended the maturity date of the convertible loan note (“CLN”) to 30 June 2025. All other terms of the CLN remain unchanged. Related Party Transaction The extension of maturity date of the CLN (the “Transaction”) is a related party transaction for the purposes of Rule 4.6 of the AQSE…

Continue reading

#TSP TruSpine Plc – Result of Aquis Disciplinary Investigation August 17, 2023 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies plc, (AQSE: TSP) the medical device company focused on the development of its pioneering “screwless,” spinal (vertebral) stabilisation systems notes the publication of the public censure and fine of £215,000 on the Company by Aquis Stock Exchange. The Company intends to appeal certain aspects of the Disciplinary Notice. Full details of the public censure and fine can be found in the Disciplinary Notice published on 16 August 2023 (see link below). https://www.aquis.eu/stock-exchange/rules-and-regulations/market-notices This…

Continue reading